Evaluation of coagulation and fibrinolytics parameters in the therapeutic management of disseminated intravascular coagulation with sepsis by low molecular weight/heparin;D-Dimer, Thrombin-Antithrombin III-Komplex (TAT) und Prothrombinfragment 1 + 2 (PTF). Parameter zur Uberwachung der Therapie mit niedermolekularem Heparin bei Gerinnungsstorungen

Anaesthesist

Volumn 46, Issue 8, 1997, Pages 689-696

  Hofmann, M ^a,b   Rest, A ^b   Hafner, G ^a   Tanner, B ^a   Brockerhoff, P ^a   Weilemann, L S ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

coagulopathy; low molecular weight heparin; sepsi

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG EFFICACY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; PLASMINOGEN ACTIVATION; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THROMBOPLASTIN TIME;

ANTICOAGULANTS; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRINOGEN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTHROMBIN; PROTHROMBIN TIME; SEPSIS;

EID: 0030805183     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050455     Document Type: Article

References (28)

1. Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T (1991) The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels - is there any difference beetwen treatment with standard heparin or low-molecular-weight heparin? Blood Coagul Fibrinolysis 2:623-627
2. Bauer KA, Rosenberg RD (1987) The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 70:343-350
3. Barthels M, Poliwoda H (1987) Gerinnungs-analysen. Thieme Verlag, Stuttgart New York, S 47
4. Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu FA (1990) A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-Dimer and fibrinogen/fibrin fragment E antigen. Br J Haematol 74:471-479
5. Bredbacka S, Blombäck M, Wiman B, Pelzer H (1993) Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects. Acta Anaesthesiol Scand 37:125-130
6. Bruhn HD, Pelzer H, Zurborn KH (1994) Thrombin-Marker: Flüherkennung der Thrombophilie. Diagnose & Labor 44:54-61
7. Carr JM, McKinney M, McDonagh J (1989) Diagnosis of disseminated intravascular coagulation, role of D-dimer. AJCP 91:280-287
8. Conway EM, Lau HK, Bauer KA, Rosenberg RD (1987) Development of a radioimmunoassay for quantitating prethrombin2 in human plasma. J Lab Clin Med 110:567-575
9. Egbring R, Fuchs G, Seitz R, Klingemann H-G, Kröniger A (1983) Gerinnungsstörungen bei akutem Leberversagen und Septikämie. Sonderdruck aus"Die gelben Hefte" 1:8-18
10. Feinstein DI (1982) Diagnosis and management of isseminated intravascular coagulation; the role of heparin therapy. Blood 60:284-287
11. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 101:816-823
12. Haas S, Haas P, Blümel G (1986) Nieder-molekulare Heparine - Eine Übersicht über Wirkprofil und bisherige Anwendung. Haemost 6:180-192
13. Hack CE, Thijs LG (1991) The orchestra of mediators in the pathogenesis of septic shock: a review. In:Vincent JL (ed) Update in intensive care and emergency medicine. Springer Berlin Heidelberg New York, S 232-246
14. Holmer E (1986) Heparin and its low molecular weight derivates: Anti-coagulant and antithrombotic properties. Haemostasis 162:1-7
15. Levi M, Ten-Cate H, van der Poll T, Van Deventer SJ (1993) Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270:975-979
16. Mant MJ, Garner King E (1979) Severe acute disseminated intravascular coagulation. A Reappraisal of its pathophysiology, clinical significance and therapy based on 47 patients. Am J Med 67:557-563
17. Rabiet MJ, Blashill A, Furie B, Furie BC (1986) Prothrombin Fragment 1+2, a major product of prothrombin activation in human plasma. J Biol Chem 261:13210-13215
18. Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M (1993) Clinical evaluation of low-molecular-weight heparin (FR 860) on disseminated intravascular coagulation (DIC) - a multi-center co-operative double-blind trial in Comparison with heparin. Thromb Res 72:475-500
19. Salzman EW, Rosenberg RD, Smith MH, London JN, Favreaul L (1980) Effect of heparin and heparin fractions on platlet aggregation. J Clin Invest 65:64-73
20. Seitz R, Wagner C (1990) Thrombose-Risiko: Thrombin-Antithrombin III-Komplex (TAT). Diagnose & Labor 40:139
21. Takahashi H, Tatewaki W, Wada K, Niwano H, Shibata A (1991) Fibrinolysis und Fibrino-genolysis in disseminated intravascular coagulation. Thromb Haemost 340-344
22. Tans G, Janssen-Claessen T, Rosing J (1989) Amidolytic detection of prothrombin activation products after SDS-gel electrophoresis Thromb Haemost 61:386-391
23. Tazawa S, Ichikawa K, Misawa K, Fukuyama J, Hamano S, Miyata H, Sakuragawa N (1995) Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits. Thromb Res 80:391-398
24. The veterans administration systemic sepsis cooperative study group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. New Engl J Med 317:659-665
25. Thijs LG, de Boer JP, de Groot MCM, Hack CE (1993) Coagulation disorders in septic shock. Intensive Care Med 19:8-15
26. Thomas L, Trobisch H (1990) Labor und Diagnose. In: Thomas L (Hrsg) Med Verl Ges Marburg
27. Wieding JU, Eisinger G, Köstering H (1989) Diagnostik der desseminierten intravasalen Gerinnung: Aussagekraft von löslichem Fibrin, D-Dimeren und Fibrin(ogen)-Spaltprodukten. Klin Wochenschr 67:764-773
28. Wüst TH, Beeser H, Lang HR (1990) Diagnostik und Therapie der Verbrauchskoagulopathie. Intensivmedizin 27:177-182